Page 63 - 2020Taiwan Food and Drug Administration Annual Report
P. 63

technology, to discuss the technical details and administrative regulations of NPS urine testing.
                     Moreover, the “Regulations Governing Accreditation and Management of Drug Abuse Urine
                     Testing and Medical Institutions´ ZDV DPHQGHG WR HQKDQFH WKH UHJXODWRU\ ÀH[LELOLW\ DW WKH HQG
                     RI       WR IDFLOLWDWH WKH WHVWLQJ FDSDELOLWLHV DQG VSHHG XS WR REWDLQ WKH FHUWL¿FDWHV IRU LQVSHFWLRQ
                     institutions.
                         TFDA has established a Drug Abuse Reporting System (DARS) to receive information
                     through drug abuse cases reported monthly by healthcare facilities in the country, to obtain the
                     epidemiological information of drug abuse cases in the nation.

                     II. Management and reporting of approved institutions for drug abuse urine

                        tests
                         As of the end of 2019, there were totally 16 approved institutions for drug abuse urine tests
                     and designated testing institutions in the country. The approved testing institutions will regularly
                     submit the inspection results to TFDA Urine Test for Drug Abuse Reporting System (UDARS)
                     on a monthly basis. The routine performance monitoring for the approved institutions will be
                     conducted every season, and 64 times combined for the approved institutions in 2019.

                     ,,,  1RQ XULQH  'UXJ  WHVWLQJ DQG UHSRUWLQJ XSRQ GUXJ DEXVH
                         According to the division of labor in drug testing of the Ministry of Justice, there are 11
                     institutions in Taiwan at present to help prosecution, police and investigation authorities test
                     non-urine specimens for drug abuse. In accordance with Article 9-3 of the “Enforcement Rules
                     of Narcotics Hazard Prevention Act,” each of the testing institutions regularly report the illegal

                     drugs testing results to TFDA UDARS, then TFDA collects the statistical data on a monthly
                     basis, including the positive results of non-urine specimens in suspicious drug and controlled
                     drug cases; the statistical data can be used as a reference for TFDA and all departments to
                     stipulate illegal drug prevention strategy.



                     $FKLHYHPHQWV DQG %HQH¿WVFKLHYHPHQWV DQG %HQH¿WV
                     $
                     I. Reporting situation of drug abuse at healthcare facilities
                         The analysis data of DARS showed that there were 34,195 cases in total reported for drug
                     abuse by healthcare facilities in 2019. The top three types of drug abuse case number included
                     heroin(16,981, 49.7%), (meth)amphetamine(13,038, 38.1%) and ketamine(1,760, 5.1%).

                     Compare with the data of drug abuse reporting in 2018, the percentage of (meth)amphetamine
                     reporting decreased from 39.6% in 2018 to 38.1% in 2019. It showed that the government had
                     achieved results in (meth)amphetamine control.








                                                                                                           61
   58   59   60   61   62   63   64   65   66   67   68